《JAMA,3月13日,Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-14
  • Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy

    Early Experience and Forecast During an Emergency Response

    Giacomo Grasselli, MD1,2; Antonio Pesenti, MD1,2; Maurizio Cecconi, MD3

    JAMA. Published online March 13, 2020. doi:10.1001/jama.2020.4031

    On February 20, 2020, a patient in his 30s admitted to the intensive care unit (ICU) in Codogno Hospital (Lodi, Lombardy, Italy) tested positive for a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). He had a history of atypical pneumonia that was not responding to treatment, but he was not considered at risk for COVID-19 infection.1 The positive result was immediately reported to the Lombardy health care system and governmental offices. During the next 24 hours, the number of reported positive cases increased to 36. This situation was considered a serious development for several reasons: the patient (“patient 1”) was healthy and young; in less than 24 hours, 36 additional cases were identified, without links to patient 1 or previously identified positive cases already in the country; it was not possible to identify with certainty the source of transmission to patient 1 at the time; and, because patient 1 was in the ICU and there were already 36 cases by day 2, chances were that a cluster of unknown magnitude was present and additional spread was likely.

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2763188?resultClick=1
相关报告
  • 《JAMA,3月23日,Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy Graziano Onder, MD, PhD1; Giovanni Rezza, MD2; Silvio Brusaferro, MD3 Author Affiliations Article Information JAMA. Published online March 23, 2020. doi:10.1001/jama.2020.4683 Only 3 cases of coronavirus disease 2019 (COVID-19) were identified in Italy in the first half of February 2020 and all involved people who had recently traveled to China. On February 20, 2020, a severe case of pneumonia due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was diagnosed in northern Italy’s Lombardy region in a man in his 30s who had no history of possible exposure abroad. Within 14 days, many other cases of COVID-19 in the surrounding area were diagnosed, including a substantial number of critically ill patients.1 On the basis of the number of cases and of the advanced stage of the disease it was hypothesized that the virus had been circulating within the population since January.
  • 《MedRxiv,3月20日,Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach.》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-22
    • Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach. Lucia Russo, Cleo Anastassopoulou, Athanassios Tsakris, Gennaro Nicola Bifulco, Emilio Fortunato Campana, Gerardo Toraldo, Constantinos Siettos doi: https://doi.org/10.1101/2020.03.17.20037689 Abstract Since the first suspected cluster of cases of coronavirus disease-2019 (COVID-19) on December 1st, 2019, in Wuhan, Hubei Province, China, a total of 195,892 confirmed infected cases, 80,840 recovered and 7,865 deaths have been reported worldwide up to March 16, 2020. After China, Italy is currently at the forefront of the combat against the epidemic that has now spread to all 22 Italian regions. The disease is sweeping through Lombardy, which remains in lockdown since the 8th of March. As of the same day, the isolation measures taken in Lombardy have been extended to the entire country. On March 11, the WHO declared COVID-19 pandemic. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.